Riccetti N, Blettner M, Taylor K, Wehler B, et al. Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS. J Cancer Res Clin Oncol 2022 May 24. pii: 10.1007/s00432-022-03975.
PMID: 35608689